NEW YORK (TheStreet) -- RATINGS CHANGES Amazon was initiated at Barclays with an equal-weight rating. Breadth of offering, depth of distribution network and consistency of shipping has made Amazon a dominant player, Barclays said. Twelve-month price target is $330. Facebook was initiated at Barclays with an overweight rating. User growth has been healthy and company is executing exceptionally well, Barclays said. Twelve-month price target is $78. Google was initiated at Barclays with an overweight rating. Offers broadest set of products and services with very high barriers to entry, Barclays said. Twelve-month price target is $650. Netflix was initiated at Barclays with an underweight rating. Valuation call as international profitability lagging, Barclays said. Twelve-month price target is $390. Pinnacle Foods was upgraded at RBC Capital to outperform from sector perform. Twelve-month price target is $36. Company is poised to return to its M&A strategy and can deliver stronger core growth than its peers, RBC Capital said. Parexel was upgraded at Robert Baird to outperform. Twelve-month price target is $64. Company hosted a solid investor day and can expand margins, Baird said. United Continental was downgraded at Imperial to in-line from outperform. Twelve-month price price target is $47. Company could continue to lag its peers for several quarters, Imperial said. Zulily was upgraded at RBC Capital to outperform. Twelve-month price target is $50. Company can continue to expand beyond children's apparel, RBC Capital said. Editor's note: To see analysts' stock comments and changes to price targets and earnings estimates, go to "Street Notes" which is available only to Real Money subscribers. To find out how to become a subscriber, please click here. Follow TheStreet on Twitter and become a fan on Facebook. Barclays Charged With Fraud Over Dark Pool Will This Ratings Call Help Facebook?
Click to view a price quote on AMZN. Click to research the Retail industry.
from Latest TSC Headlines http://ift.tt/1nHkZBI
No comments:
Post a Comment